<?xml version="1.0" encoding="UTF-8"?>
<p>The Department of Health commissioned Carter report into UK pathology services noted the importance of developing clinically relevant point-of-care diagnostic tests to reduce turnaround times and improve patient pathways [
 <xref ref-type="bibr" rid="CR46">46</xref>]. The UK Medicines and Healthcare products Regulatory Agency (MHRA) document ‘Management and Use of Point-of-Care Test Devices’ sets out the context in which POCT should be considered for use and provides guidelines for their successful and safe implementation [
 <xref ref-type="bibr" rid="CR47">47</xref>]. The objectives of this study are in line with these documents and it aims to examine the initial phase of a POCT programme: establishing a clinical need for the test and evaluating potential clinical benefits.
</p>
